EICHORCondition: Seasonal Influenza · Sponsor: ModernaTX, Inc.
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
The primary objectives of this study are to evaluate the safety and reactogenicity of mRNA-1010, and to evaluate relative vaccine efficacy (rVE) of mRNA-1010 versus an active comparator against reverse transcription polymerase chain reaction (RT-PCR)-confirmed protocol-defined influenza-like illness (ILI) caused by any influenza A or B strains.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Pinnacle Research Group, Llc | Anniston, Alabama, United States | — |
| North Alabama Research Center, LLC | Athens, Alabama, United States | — |
| Flourish Research | Birmingham, Alabama, United States | — |
| EmVenio Research Brimingham, AL | Birmingham, Alabama, United States | — |
| Cullman Clinical Trials | Cullman, Alabama, United States | — |
| Optimal Research | Huntsville, Alabama, United States | — |
| Velocity Clinical Research | Mobile, Alabama, United States | — |
| Lenzmeier Family Medicine | Glendale, Arizona, United States | — |
| DM Clinical Research | Phoenix, Arizona, United States | — |
| Helios Clinical Research | Phoenix, Arizona, United States | — |
| Fiel Family and Sports Medicine | Tempe, Arizona, United States | — |
| Arizona Liver Health | Tucson, Arizona, United States | — |
+ 289 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06602024